Brand:
Peptide Hubs
Manufacturer:
Peptide Hubs
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<p>Adipotide is typically administered subcutaneously in the abdominal area or other fat-prone regions. Users report noticeable results after 10–20 days of consistent micro-dosing. For enhanced effects, some users stack it with Clenbuterol or HCG 2500 IU during fat-loss phases.</p>
<h3>Typical Adipotide Cycle</h3>
<ul>
<li><strong>Duration:</strong> 10 to 20 days</li>
<li><strong>Daily Dosage:</strong> 0.25–0.5 mg subcutaneously</li>
<li><strong>Post-Cycle Rest:</strong> 2 to 4 weeks</li>
</ul>
<p>Due to its potent mechanism, cycling is essential to avoid overuse or adaptation. During the cycle, many users also incorporate MK-677 for appetite control and recovery support.</p>
<h3>Stacking Options</h3>
<p>While Adipotide is effective on its own, advanced users often create synergy with other compounds such as:</p>
<ul>
<li>AOD 9604 – for additional fat-burning effects</li>
<li>GHK-CU 50 mg – to support tissue regeneration</li>
<li>Semax – for enhanced cognitive function during cutting cycles</li>
</ul>
<p>Adipotide stacks particularly well with growth hormone releasing peptides or fragments.</p>
<h3>Potential Side Effects</h3>
<p>While not hepatotoxic or aromatizing, Adipotide can lead to localized soreness or mild fatigue in some users. Monitoring hydration and overall health markers is encouraged during use. Users should avoid using it for prolonged periods without medical supervision.</p>
<h3>Legality and Research Status</h3>
<p>Adipotide remains a research chemical and is not FDA-approved for human use. It is intended for research purposes only and sold under that classification.</p>
</section>
</div>
Technical Details
Compound Type
Chimeric Peptidomimetic
Peptide Sequence
CKGGRAKDC-GG-D(KLAKLAK)₂
Molecular Formula
C₁₁₁H₂₀₆N₃₆O₂₈S₂
Molecular Weight
2557.2 g/mol
Research Target
Adipose Vasculature
Development Status
Experimental / Research Use